Understanding Side Effects: How Many People Get Side Effects from Ozempic?

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What Percentage of People Experience Semaglutide Side Effects?

Clinical trials of semaglutide for weight loss show that approximately 60–75% of participants report at least one gastrointestinal side effect during treatment. The most common side effect is nausea, reported by about 40–50% of users, followed by vomiting (10–20%), diarrhea (15–25%), and constipation (10–20%). These percentages represent mild to moderate symptoms in the majority of cases. It's important to note that side effect frequency and severity both decrease significantly after 4–8 weeks of continuous use as your digestive system adapts to the medication.

Serious adverse events occur in less than 5% of semaglutide users in clinical settings, and most are reversible once treatment is adjusted or stopped. Pancreatitis, a rare but serious concern, was reported in fewer than 0.1% of trial participants. Thyroid concerns are theoretical based on animal studies and have not been conclusively linked to human weight loss doses. The overall safety profile improves when dosing is gradual—the reason PlexusDx emphasizes slow titration protocols tailored to individual tolerance.

Why Do Some People Get Severe Side Effects While Others Don't?

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Beyond genetics, factors like stomach emptying speed, gut microbiome composition, prior medication history, and baseline metabolic health all influence individual responses. Someone with slower gastric motility may experience more nausea initially, while another person's microbiome may be more resilient to GLP-1's effects on appetite signaling. This is why one-size-fits-all dosing often fails: without understanding your individual biology, providers must use trial-and-error dosing, which typically means starting too high and causing unnecessary side effects. PlexusDx's genetic insights let you start at a dose that matches your predicted tolerance, reducing the risk of early discontinuation.

How Does Compounded Semaglutide Compare to Brand-Name Ozempic for Side Effects?

PlexusDx compounded semaglutide is manufactured by licensed 503A compounding pharmacies under strict pharmaceutical-grade standards and contains the identical active ingredient as brand-name Ozempic. The side effect profile is essentially the same because the chemical compound is the same; differences in tolerability arise from dosing flexibility and titration strategy, not from the source of the medication. Many patients report better experiences on compounded semaglutide simply because their provider can customize the dose and frequency in smaller increments, which reduces the severity of initial nausea and allows the body to adapt more gradually.

A key advantage of compounded options is cost flexibility and accessibility: PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required, no membership fees, and HSA/FSA eligibility. Because the medication is more affordable and accessible, patients are less likely to skip doses or discontinue treatment due to cost, which ironically can lead to worse side effects when dosing becomes irregular. Consistent, personalized dosing—enabled by PlexusDx's lower price point and genetic testing—typically results in fewer and milder side effects compared to patients who delay doses or attempt to manage side effects through inconsistent use.

Managing and Minimizing Side Effects: A Personalized Approach

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

If nausea or other side effects become bothersome despite slow dosing, several options exist before stopping treatment. Some patients benefit from oral rather than injectable semaglutide, which can be titrated more flexibly; PlexusDx offers Oral Semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan for this reason. Others find symptom relief by adjusting meal timing or composition, taking ginger or peppermint supplements, or temporarily pausing dose escalation. Your PlexusDx provider can also recommend anti-nausea medication if needed. The key is that personalized dosing and genetic insights make it possible to find a regimen that works for your biology, rather than abandoning treatment because standard dosing schedules didn't fit your individual tolerance.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long do semaglutide side effects typically last?

Most gastrointestinal side effects peak during the first 1–2 weeks after a dose increase and improve significantly within 4–8 weeks as your body adapts. Nausea and vomiting typically become much milder or resolve entirely by week 4 of consistent dosing. Slow titration protocols used by PlexusDx often compress this timeline further because side effects are less severe when starting doses are lower and increases are gradual.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test identifies variants in GIPR and MC4R, and other peptide pathways that correlate with medication sensitivity and GI symptom risk. While genetics don't determine side effects with absolute certainty, they reveal your biological predispositions, allowing your provider to customize your starting dose and titration schedule to minimize nausea and other effects from day one.

Is compounded semaglutide from PlexusDx safe?

Yes. PlexusDx compounds semaglutide through licensed 503A compounding pharmacies that follow strict pharmaceutical-grade manufacturing standards. The active ingredient is identical to brand-name Ozempic, and safety monitoring is the same. The affordability ($149/month to start) and dosing flexibility of compounded semaglutide often lead to better tolerability than brand medication because providers can customize your dose more precisely.

What should I do if I experience severe nausea on semaglutide?

First, pause dose escalation and maintain your current dose for 4–8 weeks while your body adjusts. Try smaller, lower-fat meals and stay hydrated. If nausea persists, talk to your PlexusDx provider about switching to Oral Semaglutide (is $289/mo month-to-month (or $249/mo on the 6-month plan)), which can be titrated differently, or discuss anti-nausea support. Rarely, treatment may need to be stopped, but most side effects resolve with slower dosing.

Can the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

Yes. The Precision Peptide Genetic Test ($298) maps your response across 49 peptides and 14 pathways, including GLP-1 and GIP receptor pathways. This reveals whether you're predicted to respond better to single-pathway semaglutide or dual-pathway tirzepatide, and whether you're likely to tolerate higher doses or need slower titration. PlexusDx offers both options: Compounded Semaglutide Injection (is $189/mo month-to-month (or $149/mo on the 6-month plan)) and Compounded Tirzepatide Injection (is $289/mo month-to-month (or $249/mo on the 6-month plan)).

Related Reading

• Ozempic Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.